Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Matucci

Showing results (61-70 of 156) with videos related to

Pageof 16
Sort By:
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|October 15, 2024
Effects of Mepolizumab in the treatment of type 2 CRSwNP: a real-life clinical studyPietro Orlando, Emanuele Vivarelli, Alberto Minzoni, et al.
Allergy, Asthma & Immunology Research|July 9, 2020
Low-Dose Mepolizumab Effectiveness in Patients Suffering From Eosinophilic Granulomatosis With PolyangiitisAlessandra Vultaggio, Francesca Nencini, Susanna Bormioli, et al.
Frontiers in Immunology|January 29, 2019
T Cell Response to Infliximab in Exposed Patients: A Longitudinal AnalysisSara Pratesi, Francesca Nencini, Francesca Grosso, et al.
Antibiotics (Basel, Switzerland)|August 26, 2022
The Monitoring of <i>Mycoplasma gallisepticum</i> Minimum Inhibitory Concentrations during the Last Decade (2010-2020) Seems to Reveal a Comeback of Susceptibility to Macrolides, Tiamulin, and LincomycinMarco Bottinelli, Michele Gastaldelli, Micaela Picchi, et al.
The Laryngoscope|April 23, 2025
Sustained Efficacy and Low Rate of Adverse Events of Dupilumab in Type-2 CRSwNP Over 48 MonthsPietro Orlando, Giuseppe Licci, Gennaro Illiano, et al.
Microbes and Infection|May 17, 2006
Induction of human immunodeficiency virus neutralizing antibodies using fusion complexesDonato Zipeto, Andrea Matucci, Chiara Ripamonti, et al.
Biomedicines|March 29, 2023
EGPA Phenotyping: Not Only ANCA, but Also EosinophilsAndrea Matucci, Emanuele Vivarelli, Margherita Perlato, et al.
Expert Opinion on Biological Therapy|January 28, 2021
Self-administration of omalizumab: why not? A literature review and expert opinionFrancesco Menzella, Emanuele Ferrari, Silvia Mariel Ferrucci, et al.
European Journal of Heart Failure|July 11, 2006
Tako-Tsubo-like syndrome during anaphylactic reactionAlessandra Vultaggio, Andrea Matucci, Stefano Del Pace, et al.
The Journal of Allergy and Clinical Immunology|July 20, 2010
Impaired TH2 response in patients with Vav1-deficient common variable immunodeficiency with T-cell defectsNagaja Capitani, Amedeo Amedei, Silvia Rossi Paccani, et al.
Pageof 16

Showing results (61-70 of 156) with videos related to

Sort By:
Pageof 16
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|October 15, 2024
Effects of Mepolizumab in the treatment of type 2 CRSwNP: a real-life clinical studyPietro Orlando, Emanuele Vivarelli, Alberto Minzoni, et al.
Allergy, Asthma & Immunology Research|July 9, 2020
Low-Dose Mepolizumab Effectiveness in Patients Suffering From Eosinophilic Granulomatosis With PolyangiitisAlessandra Vultaggio, Francesca Nencini, Susanna Bormioli, et al.
Frontiers in Immunology|January 29, 2019
T Cell Response to Infliximab in Exposed Patients: A Longitudinal AnalysisSara Pratesi, Francesca Nencini, Francesca Grosso, et al.
Antibiotics (Basel, Switzerland)|August 26, 2022
The Monitoring of <i>Mycoplasma gallisepticum</i> Minimum Inhibitory Concentrations during the Last Decade (2010-2020) Seems to Reveal a Comeback of Susceptibility to Macrolides, Tiamulin, and LincomycinMarco Bottinelli, Michele Gastaldelli, Micaela Picchi, et al.
The Laryngoscope|April 23, 2025
Sustained Efficacy and Low Rate of Adverse Events of Dupilumab in Type-2 CRSwNP Over 48 MonthsPietro Orlando, Giuseppe Licci, Gennaro Illiano, et al.
Microbes and Infection|May 17, 2006
Induction of human immunodeficiency virus neutralizing antibodies using fusion complexesDonato Zipeto, Andrea Matucci, Chiara Ripamonti, et al.
Biomedicines|March 29, 2023
EGPA Phenotyping: Not Only ANCA, but Also EosinophilsAndrea Matucci, Emanuele Vivarelli, Margherita Perlato, et al.
Expert Opinion on Biological Therapy|January 28, 2021
Self-administration of omalizumab: why not? A literature review and expert opinionFrancesco Menzella, Emanuele Ferrari, Silvia Mariel Ferrucci, et al.
European Journal of Heart Failure|July 11, 2006
Tako-Tsubo-like syndrome during anaphylactic reactionAlessandra Vultaggio, Andrea Matucci, Stefano Del Pace, et al.
The Journal of Allergy and Clinical Immunology|July 20, 2010
Impaired TH2 response in patients with Vav1-deficient common variable immunodeficiency with T-cell defectsNagaja Capitani, Amedeo Amedei, Silvia Rossi Paccani, et al.
Pageof 16